Gene delivery for genetically engineered mucosal cells with enhanced function

[1]  M. Yarmush,et al.  Targeted expression of insulin-like growth factor to human keratinocytes: modification of the autocrine control of keratinocyte proliferation. , 1996, The Journal of investigative dermatology.

[2]  R. Tompkins,et al.  Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice--implications for the use of genetically modified keratinocytes to modulate dermal regeneration. , 1995, The Journal of investigative dermatology.

[3]  F. Watt,et al.  Towards gene therapy for haemophilia B using primary human keratinocytes , 1993, Nature Genetics.

[4]  T. Kaneda,et al.  In Vitro Fabrication of Bioartificial Mucosa for Reconstruction of Oral Mucosa: Basic Research and Clinical Application , 1991, Annals of plastic surgery.

[5]  Y. Barrandon,et al.  Expression of an exogenous growth hormone gene by transplantable human epidermal cells. , 1987, Science.

[6]  I. Verma,et al.  Towards gene therapy for hemophilia B. , 1987, Molecular biology & medicine.

[7]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[8]  K. Yagi,et al.  Novel Liposomes for Efficient Transfection of β-Galactosidase Gene into COS-1 Cells , 1989 .

[9]  H Green,et al.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.